Drupal.behaviors.print = function(context) {window.print();window.close();}>
SeqWright to Use 454, NimbleGen Tools in Eli Lilly Collaboration
July 30, 2009
SeqWright to Use 454, NimbleGen Tools in Eli Lilly Collaboration
By a GenomeWeb staff reporter
SeqWright will use the sequencing and sequence capture technologies to identify disease variants.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Roche, SeqWright to Collaborate on Cardio Variants Research
June 5, 2009 / GenomeWeb Daily News
Eli Lilly Taps SeqWright to Use Roche NimbleGen and 454 Tools in Psychiatric Diseases Study
August 4, 2009 / BioArray News
SeqWright, Eli Lilly to Use NimbleGen Capture, 454 Sequencing to Study Psychiatric Diseases
August 4, 2009 / In Sequence
In Applied Science Restructuring, Roche Exits Microarrays, Bundles 'Sequencing Solutions,' R&D
June 12, 2012 / In Sequence
Illumina Sends Third Letter Asking Shareholders to Reject Roche Bid, Roche Disappointed by Illumina's Continued Rebuff
April 3, 2012 / GenomeWeb Daily News